Hamilton Thorne Balans Gezondheid

Financiële gezondheid criteriumcontroles 4/6

Hamilton Thorne heeft een totaal eigen vermogen van $63.1M en een totale schuld van $20.2M, wat de schuld-eigenvermogensverhouding op 32% brengt. De totale activa en totale passiva bedragen respectievelijk $107.8M en $44.7M. De EBIT Hamilton Thorne is $486.4K waardoor de rentedekking 0.3 is. Het heeft contanten en kortetermijnbeleggingen van $9.0M.

Belangrijke informatie

32.0%

Verhouding schuld/eigen vermogen

US$20.22m

Schuld

Rente dekkingsratio	0.3x
Contant	US$8.99m
Aandelen	US$63.12m
Totaal verplichtingen	US$44.71m
Totaal activa	US$107.83m

Recente financiële gezondheidsupdates

These 4 Measures Indicate That Hamilton Thorne (CVE:HTL) Is Using Debt Reasonably Well

Aug 15

Recent updates

A Piece Of The Puzzle Missing From Hamilton Thorne Ltd.'s (TSE:HTL) 47% Share Price Climb

Jul 29

These 4 Measures Indicate That Hamilton Thorne (CVE:HTL) Is Using Debt Reasonably Well

Aug 15

At CA$1.40, Is Hamilton Thorne Ltd. (CVE:HTL) Worth Looking At Closely?

May 25

Is Hamilton Thorne (CVE:HTL) Using Too Much Debt?

Mar 30

These 4 Measures Indicate That Hamilton Thorne (CVE:HTL) Is Using Debt Safely

Oct 05

Should You Think About Buying Hamilton Thorne Ltd. (CVE:HTL) Now?

Jun 10

Hamilton Thorne (CVE:HTL) Will Be Hoping To Turn Its Returns On Capital Around

May 15

Is Hamilton Thorne (CVE:HTL) A Risky Investment?

Apr 12

Estimating The Fair Value Of Hamilton Thorne Ltd. (CVE:HTL)

Mar 15

When Should You Buy Hamilton Thorne Ltd. (CVE:HTL)?

Mar 01

Has Hamilton Thorne (CVE:HTL) Got What It Takes To Become A Multi-Bagger?

Feb 01

Announcing: Hamilton Thorne (CVE:HTL) Stock Soared An Exciting 590% In The Last Five Years

Jan 19

Are Insiders Selling Hamilton Thorne Ltd. (CVE:HTL) Stock?

Jan 06

What Did Hamilton Thorne's (CVE:HTL) CEO Take Home Last Year?

Dec 24

We Think Hamilton Thorne (CVE:HTL) Can Stay On Top Of Its Debt

Dec 12

Is It Time To Consider Buying Hamilton Thorne Ltd. (CVE:HTL)?

Nov 30

A Look At The Fair Value Of Hamilton Thorne Ltd. (CVE:HTL)

Nov 17

Analyse van de financiële positie

Kortlopende schulden: De korte termijn activa ( $35.1M ) HTL } overtreffen de korte termijn passiva ( $19.7M ).

Langlopende schulden: De kortetermijnactiva HTL ( $35.1M ) overtreffen de langetermijnschulden ( $25.0M ).

Schuld/ eigen vermogen geschiedenis en analyse

Schuldniveau: De netto schuld/eigen vermogen ratio ( 17.8% ) HTL wordt als voldoende beschouwd.

Schuld verminderen: De schuld/eigen vermogen-ratio van HTL is de afgelopen 5 jaar gestegen van 24.9% naar 32%.

Schuldendekking: De schuld van HTL wordt goed gedekt door de operationele kasstroom ( 33.7% ).

Rentedekking: De rentebetalingen van HTL op haar schulden worden niet goed gedekt door EBIT ( 0.3 x dekking).

Hamilton Thorne Balans Gezondheid

Financiële gezondheid criteriumcontroles 4/6

Belangrijke informatie

Recente financiële gezondheidsupdates

These 4 Measures Indicate That Hamilton Thorne (CVE:HTL) Is Using Debt Reasonably Well

Is Hamilton Thorne (CVE:HTL) Using Too Much Debt?

These 4 Measures Indicate That Hamilton Thorne (CVE:HTL) Is Using Debt Safely

Is Hamilton Thorne (CVE:HTL) A Risky Investment?

We Think Hamilton Thorne (CVE:HTL) Can Stay On Top Of Its Debt

Recent updates

Second quarter 2024 earnings released: US$0.003 loss per share (vs US$0.003 loss in 2Q 2023)

Hamilton Thorne Ltd. to Report Q2, 2024 Results on Aug 14, 2024

A Piece Of The Puzzle Missing From Hamilton Thorne Ltd.'s (TSE:HTL) 47% Share Price Climb

New minor risk - Share price stability

First quarter 2024 earnings: Revenues exceed analysts expectations while EPS lags behind

Hamilton Thorne Ltd. to Report Q1, 2024 Results on May 14, 2024

Hamilton Thorne Ltd., Annual General Meeting, Jun 11, 2024

Full year 2023 earnings released: US$0.004 loss per share (vs US$0.013 profit in FY 2022)

Hamilton Thorne Ltd. Provides Earnings Guidance for the First Quarter 2024 and Full Twelve Months of 2024

Hamilton Thorne Ltd. to Report Q4, 2023 Results on Mar 27, 2024

Hamilton Thorne Ltd. Announces CEO Changes, Effective January 15, 2024

New major risk - Revenue and earnings growth

Hamilton Thorne Ltd. to Report Q3, 2023 Results on Nov 13, 2023

Hamilton Thorne Ltd. (TSX:HTL) agreed to acquire Gynetics Medical Products N.V. for an enterprise value of €18.3 million.

Consensus EPS estimates increase by 80%

New minor risk - Shareholder dilution

Hamilton Thorne Ltd.(TSXV:HTL) dropped from S&P/TSX Venture Composite Index

Consensus EPS estimates fall by 80%

Second quarter 2023 earnings released: US$0.003 loss per share (vs US$0.002 profit in 2Q 2022)

These 4 Measures Indicate That Hamilton Thorne (CVE:HTL) Is Using Debt Reasonably Well

Hamilton Thorne Ltd. to Report Q2, 2023 Results on Aug 17, 2023

Consensus EPS estimates fall by 50%

First quarter 2023 earnings released: EPS: US$0.001 (vs US$0.004 in 1Q 2022)

Hamilton Thorne Ltd. to Report Q1, 2023 Results on May 15, 2023

Chair, President & CEO exercised options to buy CA$102k worth of stock.

Chair, President & CEO recently sold CA$101k worth of stock

Full year 2022 earnings: EPS misses analyst expectations

Now 22% undervalued after recent price drop

Now 20% undervalued

Consensus EPS estimates increase by 17%

Now 20% undervalued after recent price drop

Hamilton Thorne Ltd. Announces Passing of Diarmaid Douglas-Hamilton, Cofounder and Chief Technology Officer

Now 21% undervalued after recent price drop

Hamilton Thorne Ltd. (TSXV:HTL) agreed to acquire Microptic, S.L.

Consensus EPS estimates fall by 33%

Hamilton Thorne Ltd. Provides Sales Guidance for the Year 2022

Third quarter 2022 earnings released: EPS: US$0.001 (vs US$0.002 in 3Q 2021)

High number of new directors

Hamilton Thorne Ltd. to Report Nine Months, 2022 Results on Nov 22, 2022

Consensus EPS estimates fall by 23%

Second quarter 2022 earnings: EPS and revenues miss analyst expectations

Hamilton Thorne Ltd. to Report Q2, 2022 Results on Aug 23, 2022

Hamilton Thorne Ltd. Announces CFO Changes

Chair, President exercised options to buy CA$86k worth of stock.

Chair, President exercised options to buy CA$886k worth of stock.

Consensus EPS estimates fall by 20%

At CA$1.40, Is Hamilton Thorne Ltd. (CVE:HTL) Worth Looking At Closely?

First quarter 2022 earnings: EPS and revenues miss analyst expectations

Hamilton Thorne Ltd. to Report Q1, 2022 Results on May 19, 2022

Investor sentiment deteriorated over the past week

High number of new directors

Hamilton Thorne Ltd., Annual General Meeting, Jun 14, 2022

Full year 2021 earnings: EPS exceeds analyst expectations

Chair, President exercised options to buy CA$293k worth of stock.

Hamilton Thorne Ltd. to Report Q4, 2021 Results on Apr 07, 2022

Is Hamilton Thorne (CVE:HTL) Using Too Much Debt?

High number of new directors

President recently bought CA$75k worth of stock

President recently sold CA$635k worth of stock

Third quarter 2021 earnings: EPS and revenues miss analyst expectations

These 4 Measures Indicate That Hamilton Thorne (CVE:HTL) Is Using Debt Safely

Second quarter 2021 earnings released: EPS US$0.003 (vs US$0.004 loss in 2Q 2020)

Hamilton Thorne Ltd. (TSXV:HTL) acquired IVFTECH ApS and K4 Technology ApS for an enterprise value of approximately DKK 50 million ($8 million).

President exercised options to buy CA$115k worth of stock.

Should You Think About Buying Hamilton Thorne Ltd. (CVE:HTL) Now?

Consensus EPS estimates increase to US$0.028

First quarter 2021 earnings released: EPS US$0.006 (vs US$0.001 in 1Q 2020)

Hamilton Thorne (CVE:HTL) Will Be Hoping To Turn Its Returns On Capital Around

Independent Director recently bought CA$107k worth of stock

Is Hamilton Thorne (CVE:HTL) A Risky Investment?